Ablative treatments for cervical intraepithelial neoplasia: the challenge now is implementation. The Lancet Obstetrics, Gynaecology, & Women’s Health, 2025 – ARROSSILAB

Ablative treatments for cervical intraepithelial neoplasia: the challenge now is implementation. The Lancet Obstetrics, Gynaecology, & Women’s Health, 2025

Authors

Arrossi S.

Publication

The Lancet Obstetrics, Gynaecology, & Women's Health, Volume 1, Issue 4, 2025, Pages e247-e248, ISSN 3050-5038

OUTSTANDING PUBLICATIONS

Effectiveness of an mHealth intervention to increase adherence to triage of HPV DNA positive women who have performed self-collection (the ATICA study): A hybrid type I cluster randomised effectiveness-implementation trial. Lancet Reg Health Am., 2022.

The IARC Perspective on Cervical Cancer Screening. N Engl J Med., 2021

See all publications